Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Conditions:   Atypical Endometrial Hyperplasia;   Endometrial Carcinoma Stage I Intervention:   Drug: Medroxyprogesterone acetate + Atorvastatin Sponsor:   Peking University People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions
Condition:   Bioequivalence Intervention:   Drug: Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg Sponsors:   Pharmtechnology LLC;   ClinPharmInvest, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials